Skip to content
  • Home
  • About
    • Our Research
    • Funding
    • Organization
  • Studies
    • PTN Studies
    • Research Sites Map
    • Future Research
  • News
  • Results
    • Our Impact
    • Publications
    • Data Sharing
  • Resources
    • For Parents and Families
    • For Health Care Professionals
Search
 
twitter linkfacebook linkjoin the mailing list
return home

Pediatric Trials Network

PTN

Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status Epilepticus

Posted on August 15, 2017November 26, 2019 by Julia
This entry was posted in Adolescents, Children (2-11 years), Infants, Lorazepam, Lorazepam, Publications, Sedatives, Seizures, Status epilepticus. Bookmark the permalink.

Post navigation

← Effectiveness of Granulocyte Colony-Stimulating Factor in Hospitalized Infants with Neutropenia
Use of Population Pharmacokinetics and Electronic Health Records to Assess Piperacillin-Tazobactam Safety in Infants →
CONTACT US LEGAL
Sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.